MFG
ABBV icon

Magnus Financial Group’s AbbVie ABBV Stock Holding History

Magnus Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.72M Buy
6,845
+51
+0.8% +$11K 0.12% 113
2026
Q1 		$1.48M Buy
6,794
+54
+0.8% +$12K 0.12% 121
2025
Q4 		$1.54M Sell
6,740
-152
-2% -$34.6K 0.12% 135
2025
Q3 		$1.6M Buy
6,892
+270
+4% +$55K 0.13% 130
2025
Q2 		$1.23M Buy
6,622
+41
+0.6% +$7.62K 0.11% 145
2025
Q1 		$1.38M Buy
6,581
+104
+2% +$20.2K 0.13% 120
2024
Q4 		$1.15M Sell
6,477
-2,501
-28% -$460K 0.11% 139
2024
Q3 		$1.77M Buy
8,978
+829
+10% +$155K 0.18% 101
2024
Q2 		$1.4M Sell
8,149
-192
-2% -$31.8K 0.16% 105
2024
Q1 		$1.52M Buy
8,341
+890
+12% +$153K 0.18% 97
2023
Q4 		$1.15M Buy
7,451
+785
+12% +$114K 0.15% 115
2023
Q3 		$994K Buy
6,666
+37
+0.6% +$5.43K 0.14% 112
2023
Q2 		$893K Buy
6,629
+45
+0.7% +$6.6K 0.13% 121
2023
Q1 		$1.05M Buy
6,584
+231
+4% +$35.3K 0.16% 106
2022
Q4 		$1.03M Buy
6,353
+170
+3% +$26.1K 0.17% 104
2022
Q3 		$830K Buy
6,183
+358
+6% +$51.4K 0.16% 110
2022
Q2 		$892K Buy
5,825
+118
+2% +$18K 0.16% 107
2022
Q1 		$925K Buy
5,707
+284
+5% +$41.3K 0.15% 112
2021
Q4 		$734K Buy
5,423
+409
+8% +$48.3K 0.14% 110
2021
Q3 		$541K Buy
5,014
+42
+0.8% +$4.8K 0.11% 123
2021
Q2 		$560K Buy
4,972
+281
+6% +$31.6K 0.12% 109
2021
Q1 		$508K Sell
4,691
-4,601
-50% -$492K 0.12% 106
2020
Q4 		$996K Sell
9,292
-762
-8% -$73.2K 0.1% 76
2020
Q3 		$881K Sell
10,054
-5,060
-33% -$476K 0.1% 77
2020
Q2 		$1.48M Sell
15,114
-116
-0.8% -$10.2K 0.16% 52
2020
Q1 		$1.16M Buy
15,230
+10,502
+222% +$895K 0.16% 66
2019
Q4 		$419K Buy
4,728
+75
+2% +$6.23K 0.06% 182
2019
Q3 		$352K Buy
4,653
+856
+23% +$58.7K 0.07% 192
2019
Q2 		$276K Buy
3,797
+35
+0.9% +$2.75K 0.05% 293
2019
Q1 		$303K Sell
3,762
-1,153
-23% -$94.3K 0.06% 231
2018
Q4 		$453K Buy
+4,915
New +$432K 0.12% 97

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Magnus Financial Group's ABBV Position: Q2 2026 in Review

Magnus Financial Group increased its AbbVie (ABBV) stake by 0.75% in Q2 2026, buying an estimated $11K and bringing the position to 6,845 shares worth $1.72M. The position accounts for 0.12% of the portfolio, ranked #113.

Magnus Financial Group first reported a position in ABBV in Q4 2018 and has held it in 31 quarters since. The position peaked at $1.77M in Q3 2024. 1,395 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Magnus Financial Group held 6,845 shares of AbbVie worth $1.72M as of Q2 2026.
  • Magnus Financial Group bought 51 AbbVie shares in Q2 2026, an estimated $11K.
  • AbbVie made up 0.12% of Magnus Financial Group's portfolio in Q2 2026, its #113 holding.
  • Magnus Financial Group first reported a position in AbbVie in Q4 2018 and has held it in 31 quarters since.
  • Magnus Financial Group's AbbVie position peaked at $1.77M in Q3 2024.
  • 1,395 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Magnus Financial Group's 13F filing for Q2 2026, filed 9 Jul 2026.